Active Ingredients:
Arsenicum Album 30X, Belladonna 30X, Ipecacuanha 30X, Kali Carbonicum 30X, Lobelia Inflata 30X, Natrum Sulphuricum 30X, Silicea 30X.
Respiforce A-hp Liquid
FDA Label NDC 43857-0612
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Bioactive Nutritional, Inc. for the product Respiforce A-hp (NDC 43857-0612). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients:, indications:, warnings:, keep out of reach of children:, directions:, inactive ingredients:, questions:, package display label:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications:
For temporary relief of symptoms of tightness in the chest, wheezing, and difficulty breathing due to low oxygen to the lungs.
For temporary relief of symptoms of tightness in the chest, wheezing, and difficulty breathing due to low oxygen to the lungs.
Warnings:
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do no use if tamper evident seal is broken or missing.
Store in cool, dry place.
Keep Out Of Reach Of Children:
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions:
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Inactive Ingredients:
Demineralized Water, 25% Ethanol
Questions:
Distributed by:
BioActive Nutritional, Inc.
1803 N. Wickham Rd.
Melbourne, FL 32935
bioactivenutritional.com
Package Display Label:
BioActiveNutritional
RESPIFORCE A-HP
HOMEOPATHIC
1 FL OZ (30 mL)
* Please review the disclaimer below.
